In vitro effects of detergent sclerosants on clot formation and fibrinolysis

European Journal of Vascular and Endovascular Surgery

Volumn 41, Issue 2, 2011, Pages 267-277

  Parsi, K ^a,b,c   Exner, T ^d   Low, J ^e   Fung Ma, D D ^a,b   Joseph, J E ^a,b  

^a St Vincent's Centre for Applied Medical Research   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Phlebology Research Laboratory   (Australia)

^d Haematex Research Laboratory   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

Author keywords

Clot formation; D dimer; Detergent sclerosants; Factor XIII; Fibrinogen; Fibrinolysis

Indexed keywords

BLOOD CLOTTING FACTOR 13; D DIMER; FIBRIN; FIBRINOGEN; POLIDOCANOL; SCLEROSING AGENT; TETRADECYL SULFATE SODIUM;

ARTICLE; BLOOD CLOTTING; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; ROTATIONAL THROMBOELASTOMETRY; THROMBOCYTE; THROMBOELASTOGRAPHY;

ARTIFACTS; BLOOD COAGULATION; DETERGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR XIII; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FIBRINOLYSIS; HUMANS; KINETICS; NEPHELOMETRY AND TURBIDIMETRY; POLYETHYLENE GLYCOLS; REPRODUCIBILITY OF RESULTS; ROTATION; SCLEROSING SOLUTIONS; SODIUM TETRADECYL SULFATE; THROMBELASTOGRAPHY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 79651471971     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2010.10.004     Document Type: Article

References (28)

1. M.P. Goldman, R.P. Kaplan, L.N. Oki, P.A. Cavender, R.A. Strick, and R.G. Bennett Sclerosing agents in the treatment of telangiectasia. Comparison of the clinical and histologic effects of intravascular polidocanol, sodium tetradecyl sulfate, and hypertonic saline in the dorsal rabbit ear vein model Arch Dermatol 123 1987 1196 1201 (Pubitemid 17134622)
2. K. Parsi, T. Exner, D.E. Connor, D.D.F. Ma, and J.E. Joseph In vitro effects of detergent sclerosants on coagulation, platelets and microparticles Eur J Vasc Endovasc Surg 34 2007 731 740 (Pubitemid 350056374)
3. K. Parsi, T. Exner, J. Low, D.D.F. Ma, and J.E. Joseph In vitro effects of detergent sclerosants on antithrombotic mechanisms Eur J Vasc Endovasc Surg 38 2009 220 228
4. K. Parsi, T. Exner, D.D.F. Ma, and J.E. Joseph In vitro effects of detergent sclerosants on fibrinolytic enzymes and inhibitors Thromb Res. 126 2010 328 336
5. R.A. Ariëns, T.S. Lai, J.W. Weisel, C.S. Greenberg, and P.J. Grant Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms Blood 100 2002 743 754 (Pubitemid 34832596)
6. F. de Cataldo, and F. Baudo Sensitization of stabilized fibrin to urea dispersion by undiluted plasma and serum Acta Haematol 58 1977 79 83 (Pubitemid 8145555)
7. R.J. Luddington Thrombelastography/thromboelastometry Clin Lab Haematol 27 2005 81 90 (Pubitemid 40515992)
8. A. Clauss Rapid physiological coagulation method in determination of fibrinogen Acta Haematol 17 1957 237 246 [Article in German]
9. T. Exner, K.A. Rickard, and H. Kronenberg Fibrin powder turbidity measurement for rapid assessment of antiplasmins Am J Clin Pathol 64 1975 597 601
10. K. Parsi, T. Exner, D.E. Connor, A. Herbert, D.D.F. Ma, and J.E. Joseph The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro Eur J Vasc Endovasc Surg 36 2008 216 223 (Pubitemid 351952328)
11. J.A. Sjøland, J.J. Sidelmann, M. Brabrand, R.S. Pedersen, J.H. Pedersen, and K. Esbensen Fibrin clot structure in patients with end-stage renal disease Thromb Haemost 98 2007 339 345 (Pubitemid 47250237)
12. C. Jámbor, V. Reul, T.W. Schnider, P. Degiacomi, H. Metzner, and W.C. Korte In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood Anesth Analg 109 2009 1023 1028
13. T. Lang, W. Toller, M. Gütl, E. Mahla, H. Metzler, and P. Rehak Different effects of abciximab and cytochalasin D on clot strength in thrombelastography Thromb Haemost 2 2004 147 153 (Pubitemid 40185631)
14. E.A. Ryan, L.F. Mockros, J.W. Weisel, and L. Lorand Structural origins of fibrin clot rheology Biophys J 77 1999 2813 2826 (Pubitemid 29519524)
15. D.E. Otzen Protein unfolding in detergents: effect of micelle structure, ionic strength, pH, and temperature Biophys J 83 2002 2219 2230
16. S. Kurioka, and F. Inoue Interaction of fibrinogen with detergent J Biochem 77 1975 449 455
17. K.F. Standeven, A.M. Carter, P.J. Grant, J.W. Weisel, I. Chernysh, and L. Masova Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness Blood 110 2007 902 907 (Pubitemid 47267427)
18. T. Lang, K. Johanning, H. Metzler, S. Piepenbrock, C. Solomon, and N. Rahe-Meyer The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia Anesth Analg 108 2009 751 758
19. S.V. Pizzo, M.L. Schwartz, R.L. Hill, and P.A. McKee The effect of plasmin on the subunit structure of human fibrin J Biol Chem 248 1973 4574 4583
20. M.W. Edwards, E. Bang, J. Strout, and P.D. Bishop Recombinant factor XIII supplemented clots resist lysis by plasmin and leucocyte elastase Fibrinolysis 7 1993 211 216 (Pubitemid 23162950)
21. S. Chakrabarty Fibrin solubilizing properties of certain anionic and cationic detergents Thromb Res 55 1989 511 519 (Pubitemid 19215688)
22. A.C. Thomas, and J.H. Campbell Timecourse of fibrin deposition and removal after arterial injury Thromb Res 109 2002 65 69
23. E.K. Kruithof, A. Ransijn, and F. Bachmann Influence of detergents on the measurement of the fibrinolytic activity of plasminogen activators Thromb Res 28 1982 251 260 (Pubitemid 13253532)
24. M.W. Mosesson, K.R. Siebenlist, J.F. Hainfeld, and J.S. Wall Evidence that factor XIIIa-crosslinked fibrinogen forms double-stranded fibrils interlinked through carboxy terminal gamma chains Thromb Haemost 73 1995 1225
25. A. Bennick, U. Haddeland, and F. Brosstad D-dimer specific monoclonal antibodies react with fibrinogen aggregates Thromb Res 82 1996 169 176 (Pubitemid 26164663)
26. M.P. Goldman, J. Bergan, and J.J. Guex Sclerotherapy. Treatment of varicose and telangiectatic leg veins 2007 Mosby Elsevier USA p. 169
27. J.L. Gillet, J.M. Guedes, J.J. Guex, C. Hamel-Desnos, M. Schadeck, and M. Lauseker Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients Phlebology 24 2009 131 138
28. K.L. Chan, R.G. Summerhayes, V. Ignjatovic, S.B. Horton, and P.T. Monagle Reference values for kaolin-activated thromboelastography in healthy children Anesth Analg 105 2007 1610 1613 (Pubitemid 350190554)